The burden of primary diseases is substantial, demanding advanced therapeutic options. Cellular therapies represent a particularly promising avenue, offering the potential to regenerate damaged hepatic tissue and enhance patient outcomes. Currently, research focuses on several approaches, including the administration of mesenchymal stem cells direc